|
|
| Nomenclature |
|
Symbol:
|
Ppargtm1Rev
|
|
Name:
|
peroxisome proliferator activated receptor gamma;
targeted mutation 1, Ronald M Evans
|
|
MGI ID: |
MGI:2149838 |
|
Synonyms: |
Pparg-, PPARg- |
|
Gene:
|
Pparg
Location:
Chr6:115361221-115490401 bp, + strand
Genetic Position: Chr6,
53.41 cM, cytoband E3-F1
|
|
Mutation origin |
|
Germline Transmission:
|
Earliest citation of germline transmission:
J:58223
|
|
Parent Cell Line:
| J1 (ES Cell) |
|
Strain of Origin:
|
129S4/SvJae
|
|
Mutation description |
|
Allele
Type: | |
Targeted (Reporter) |
|
Mutation: | |
Insertion |
| |
|
Mutation details: In-frame insertion of a lac Z-neomycin resistance cassette into the second coding exon of the gene, just upstream of the DNA binding domain, eliminated both DNA-binding and ligand-binding functions of the receptor. Whole-mount beta-galactosidase assays revealed conspicuous beta-gal activivity in the interscapular brown fat pad of only E14.5 embryos carrying a targeted allele, but not in wild-type embryos (J:58223)
|
|
Phenotypes
|
View phenotypes for all genotypes (concatenated display).
|
|
Disease models
|
|
| Find Mice (IMSR) |
Mouse strains and cell lines available from the
International Mouse Strain Resource
(IMSR)
|
|
Notes |
Complementation of Ppargtm1Rev mutant embryos with wild-type placenta by tetraploid aggregation corrects the cardiac defect and extends viability to E12.5 (two mutants out of a total five), E15.5 (one out of ten) and at birth (one of six). Rescued embryos survive to term but exhibit a second lethal phase during the first week of life. Additional phenotypes include: a 30% reduction in body weight (P0-P4) and subsequent ill health (as shown by dehydration, weight loss and lethargy starting at P5) associated with lipodystrophy, a severly pale, distended and fatty liver, severe intestinal bleeding, and numerous focal hematomas throughout the brain (J:58223).
|
| References |
|
Original: |
J:58223
Barak Y et al.,
"PPAR gamma is required for placental, cardiac, and adipose tissue development."
Mol Cell 1999 Oct;4(4):585-95
|
|
All: |
12 reference(s)
|
|